Renal Cell Carcinoma Prediction Tool
Researchers at Memorial Sloan-Kettering have developed an online prediction tool, known as a nomogram, that combines prognostic factors to predict the likelihood of recurrence after surgery for renal cell carcinoma.
Late Effects of Childhood Cancer Treatment
Childhood cancer in the United States now has a five-year survival rate of 80 percent. Thanks to improved methods of treatment, most pediatric patients grow up to lead active lives. But they are also subject to future health risks. Nearly three-quarters of childhood cancer survivors will develop a chronic health problem within 30 years of diagnosis.
Stomach Cancer Patient Story
Allen was 51 when he had a strange feeling in his stomach that was diagnosed as stage 1 stomach cancer. He came to Memorial Sloan-Kettering and had minimally invasive surgery to remove his tumor. Read about his surgery and subsequent recovery.
Study Shows Drug Combination Improves Outcome for Advanced Non-Small Cell Lung Cancer
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer.
Surgery Not Necessary for Most Late-Stage Colorectal Cancers
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.
An Interview with Monica Morrow
Surgical oncologist Monica Morrow is an internationally renowned expert in breast cancer with more than 20 years of experience leading research, education, and treatment programs.
Living Beyond Cancer Calendar
A listing of upcoming survivorship events and programs hosted by Memorial Sloan-Kettering.
